Related Experiment Video
Updated: Jun 8, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Unusual risk factors for cognitive decline
Manjari Tripathi1, Deepti Vibha
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. manjari.tripathi@gmail.com
Identifying unusual causes of cognitive decline is crucial for timely diagnosis and treatment. Many reversible conditions, often masked by other factors, can be effectively managed with proper evaluation.
Area of Science:
- Neurology
- Geriatrics
- Internal Medicine
Background:
- Cognitive decline presents significant diagnostic and therapeutic challenges.
- Common reversible causes are often screened, but 'unusual' causes are frequently delayed or missed.
- Subtle cognitive changes can be masked by metabolic, nutritional, endocrine, toxic, and infectious factors, especially post-operatively.
Purpose of the Study:
- To review and highlight the recognition and evaluation of unusual causes of cognitive decline.
- To increase awareness of less common yet reversible etiologies of cognitive impairment.
- To guide clinicians in diagnosing and managing complex cognitive disorders.
Main Methods:
- Literature review focusing on unusual causes of cognitive decline.
- Analysis of diagnostic challenges and therapeutic implications.
- Synthesis of emerging factors contributing to cognitive impairment.
Main Results:
- A wide range of factors, including metabolic, nutritional, endocrine, toxic, post-operative, autoimmune, cerebrovascular, genetic, infectious, and hemorheological issues, are identified as unusual causes.
- These factors can mask progressive cognitive changes, becoming apparent under stress or after surgery.
- Early recognition of these unusual causes is key to effective management.
Conclusions:
- Awareness of unusual causes of cognitive decline is essential for accurate diagnosis.
- Many of these less common causes are reversible, emphasizing the need for comprehensive evaluation.
- This review provides a framework for recognizing and assessing these challenging clinical scenarios.
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

